Physician profile
Alison Black
NPI 1285653584
$13,913.72
in general payments reported to CMS, 2019-2025
37 companies · $3,065 in 2025
The $3,065 reported for 2025 was more than what 85% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,189 · 2020: $1,171 · 2021: $1,371 · 2022: $1,568 · 2023: $2,402 · 2024: $2,149 · 2025: $3,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,340 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,340.04 |
| Education | $274.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,094.55 | 2019-2025 | Botox, Skyrizi |
| Galderma Laboratories, L.P. | $1,683.04 | 2019-2025 | Nemluvio, Dysport, Aklief |
| Genzyme Corporation | $1,221.93 | 2019-2025 | |
| Allergan, INC. | $1,142.17 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $1,008.90 | 2020-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $904.30 | 2020-2025 | Tremfya, Simponi Aria, Stelara |
| Amgen INC. | $805.65 | 2020-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $532.32 | 2019-2025 | |
| Incyte Corporation | $531.79 | 2021-2025 | Opzelura, Opzelura |
| Almirall LLC | $379.16 | 2019-2022 | |
| Merz North America, INC. | $331.56 | 2019 | |
| Sun Pharmaceutical Industries INC. | $330.92 | 2019-2025 | Winlevi, Absorica Ld |
| Lilly USA, LLC | $327.20 | 2019-2025 | Taltz, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $293.03 | 2023-2024 | Sotyktu |
| Pfizer INC. | $269.89 | 2021-2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.